Mereo BioPharma Group plc (MAH0) — Cash Flow Quality Index

Latest as of December 2021: -23.77x

Mereo BioPharma Group plc (MAH0) has a Cash Flow Quality Index of -23.77x as of December 2021. Operating cash flow of €-7.57 Million is below net income of €318.50K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Mereo BioPharma Group plc to assess how effectively this company generates cash.

Cash Flow Quality Index

-23.77x
Operating CF / Net Income

Operating Cash Flow

€-7.57 Million
EUR

Net Income

€318.50K
EUR

Data as of

Dec 2021
Most recent filing

Mereo BioPharma Group plc Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Mereo BioPharma Group plc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MAH0 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Mereo BioPharma Group plc (2021–2021)

Year-by-year earnings quality comparison for Mereo BioPharma Group plc. For live market cap and the full company financial profile, see MAH0 stock market capitalisation.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2021 -0.41x €-5.24 Million €12.72 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.